ClosedPublished 21 Apr 2023

Vallon Pharmaceuticals, Inc. /
GRI Operations, Inc.

Vallon Pharmaceuticals and GRI Operations complete merger

Terms
Not stated
Stage
Closed
Buy side: Vallon Pharmaceuticals, Inc.
Buy sideVallon Pharmaceuticals, Inc.
Target: GRI Operations, Inc.
TargetGRI Operations, Inc.
Source · 21 Apr 2023
Buy side: Vallon Pharmaceuticals, Inc.
Buy sideVallon Pharmaceuticals, Inc.
Target: GRI Operations, Inc.
TargetGRI Operations, Inc.
01 / BuyerVallon Pharmaceuticals, Inc.
02 / TargetGRI Operations, Inc.
01

What happened

Vallon Pharmaceuticals, Inc. completed its merger with GRI Operations, Inc. on April 21, 2023. GRI Operations survived as a wholly owned subsidiary, and the combined company changed its name to GRI Bio, Inc.

Former GRI stockholders owned or held rights to acquire approximately 85% of the outstanding company common stock immediately following the merger.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Vallon Pharmaceuticals and GRI Operations complete merger

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.